The estimated Net Worth of Capital Management, Llcra C... is at least $73.1 million dollars as of 13 April 2009. Capital C owns over 1,184 units of Biospecifics Technologies stock worth over $73,111,969 and over the last 16 years Capital sold BSTC stock worth over $0.
Capital has made over 5 trades of the Biospecifics Technologies stock since 2008, according to the Form 4 filled with the SEC. Most recently Capital bought 1,184 units of BSTC stock worth $21,774 on 13 April 2009.
The largest trade Capital's ever made was buying 10,845 units of Biospecifics Technologies stock on 13 March 2009 worth over $206,923. On average, Capital trades about 6,664 units every 22 days since 2008. As of 13 April 2009 Capital still owns at least 825,844 units of Biospecifics Technologies stock.
You can see the complete history of Capital C stock trades at the bottom of the page.
Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo et Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.
Biospecifics Technologies executives and other stock owners filed with the SEC include: